PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VXRT vs. NVDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VXRT and NVDA is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

VXRT vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vaxart, Inc. (VXRT) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-16.33%
9.57%
VXRT
NVDA

Key characteristics

Sharpe Ratio

VXRT:

-0.42

NVDA:

1.56

Sortino Ratio

VXRT:

-0.14

NVDA:

2.12

Omega Ratio

VXRT:

0.98

NVDA:

1.27

Calmar Ratio

VXRT:

-0.39

NVDA:

3.28

Martin Ratio

VXRT:

-0.87

NVDA:

9.09

Ulcer Index

VXRT:

44.27%

NVDA:

9.75%

Daily Std Dev

VXRT:

92.31%

NVDA:

56.89%

Max Drawdown

VXRT:

-97.75%

NVDA:

-89.73%

Current Drawdown

VXRT:

-96.87%

NVDA:

-6.71%

Fundamentals

Market Cap

VXRT:

$171.36M

NVDA:

$3.41T

EPS

VXRT:

-$0.40

NVDA:

$2.53

Total Revenue (TTM)

VXRT:

$13.52M

NVDA:

$91.17B

Gross Profit (TTM)

VXRT:

-$5.07M

NVDA:

$69.14B

EBITDA (TTM)

VXRT:

-$48.27M

NVDA:

$60.32B

Returns By Period

In the year-to-date period, VXRT achieves a 10.26% return, which is significantly higher than NVDA's 3.81% return.


VXRT

YTD

10.26%

1M

-1.35%

6M

-16.35%

1Y

-38.91%

5Y*

-7.73%

10Y*

N/A

NVDA

YTD

3.81%

1M

1.23%

6M

9.57%

1Y

92.03%

5Y*

78.95%

10Y*

74.65%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VXRT vs. NVDA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VXRT
The Risk-Adjusted Performance Rank of VXRT is 2626
Overall Rank
The Sharpe Ratio Rank of VXRT is 2424
Sharpe Ratio Rank
The Sortino Ratio Rank of VXRT is 2828
Sortino Ratio Rank
The Omega Ratio Rank of VXRT is 2929
Omega Ratio Rank
The Calmar Ratio Rank of VXRT is 2222
Calmar Ratio Rank
The Martin Ratio Rank of VXRT is 2626
Martin Ratio Rank

NVDA
The Risk-Adjusted Performance Rank of NVDA is 8686
Overall Rank
The Sharpe Ratio Rank of NVDA is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of NVDA is 8181
Sortino Ratio Rank
The Omega Ratio Rank of NVDA is 7979
Omega Ratio Rank
The Calmar Ratio Rank of NVDA is 9595
Calmar Ratio Rank
The Martin Ratio Rank of NVDA is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VXRT vs. NVDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vaxart, Inc. (VXRT) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VXRT, currently valued at -0.42, compared to the broader market-2.000.002.004.00-0.421.56
The chart of Sortino ratio for VXRT, currently valued at -0.14, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.142.12
The chart of Omega ratio for VXRT, currently valued at 0.98, compared to the broader market0.501.001.502.000.981.27
The chart of Calmar ratio for VXRT, currently valued at -0.39, compared to the broader market0.002.004.006.00-0.393.28
The chart of Martin ratio for VXRT, currently valued at -0.87, compared to the broader market0.0010.0020.0030.00-0.879.09
VXRT
NVDA

The current VXRT Sharpe Ratio is -0.42, which is lower than the NVDA Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of VXRT and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025February
-0.42
1.56
VXRT
NVDA

Dividends

VXRT vs. NVDA - Dividend Comparison

VXRT has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.


TTM20242023202220212020201920182017201620152014
VXRT
Vaxart, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%

Drawdowns

VXRT vs. NVDA - Drawdown Comparison

The maximum VXRT drawdown since its inception was -97.75%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for VXRT and NVDA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-96.87%
-6.71%
VXRT
NVDA

Volatility

VXRT vs. NVDA - Volatility Comparison

The current volatility for Vaxart, Inc. (VXRT) is 18.65%, while NVIDIA Corporation (NVDA) has a volatility of 24.40%. This indicates that VXRT experiences smaller price fluctuations and is considered to be less risky than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
18.65%
24.40%
VXRT
NVDA

Financials

VXRT vs. NVDA - Financials Comparison

This section allows you to compare key financial metrics between Vaxart, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab